RedHill Biopharma Ltd. (RDHL) [Rocket]

In millions, except per share items	Mar-31-21	Mar-31-20	Sep-30-19	Mar-31-19	Sep-30-18	Mar-31-18	Mar-31-17
	6-K	6-K	6-K	6-K	6-K	6-K	6-K
NET REVENUES
COST OF REVENUES
GROSS PROFIT
RESEARCH AND DEVELOPMENT EXPENSES
SELLING AND MARKETING EXPENSES
GENERAL AND ADMINISTRATIVE EXPENSES
OPERATING LOSS
FINANCIAL INCOME
FINANCIAL EXPENSES

LOSS AND COMPREHENSIVE LOSS FOR THE PERIOD
LOSS PER ORDINARY SHARE, basic (U.S. dollars)
LOSS PER ORDINARY SHARE, diluted (U.S. dollars)
WEIGHTED AVERAGE OF ORDINARY SHARES (in thousands)